BackgroundCheck.run
Search For

David M Borror, 6123575 Rapp Dean Rd, Raymond, OH 43067

David Borror Phones & Addresses

23575 Rapp Dean Rd, Raymond, OH 43067    937-2462138   

17500 Springdale Rd, Marysville, OH 43040    937-6429904   

Richwood, OH   

Fresno, CA   

Commerce City, CO   

Great Falls, MT   

Delaware, OH   

Mount Gilead, OH   

17500 Springdale Rd, Marysville, OH 43040    937-2416989   

Social networks

David M Borror

Linkedin

Work

Position: Craftsman/Blue Collar

Education

Degree: High school graduate or higher

Emails

Mentions for David M Borror

Career records & work history

Lawyers & Attorneys

David Borror Photo 1

David Borror - Lawyer

Specialties:
General Practice
ISLN:
908904073
Admitted:
1982
University:
The Ohio State University, B.A., 1979; The Ohio State University, B.A., 1979
Law School:
The Ohio State University, J.D., 1982; The Ohio State University, J.D., 1982
David Borror Photo 2

David S. Borror, Dublin OH - Lawyer

Office:
5000 Tuttle Crossing Blvd., P.o. Box 5000, Dublin, OH
ISLN:
908904073
Admitted:
1982
University:
The Ohio State University, B.A.
Law School:
The Ohio State University, J.D.

David Borror resumes & CV records

Resumes

David Borror Photo 17

David Borror

Publications & IP owners

Us Patents

Process Of Making An Enteral Formula Containing Long-Chain Polyunsaturated Fatty Acids

US Patent:
6036992, Mar 14, 2000
Filed:
Mar 16, 1999
Appl. No.:
9/270423
Inventors:
David A. Borror - Westerville OH
David V. Diodato - Hilliard OH
Debra L. Ponder - Morristown NJ
Margaret H. Dohnalek - Worthington OH
Assignee:
Abbott Laboratories - Abbott Park IL
International Classification:
A23J 700
A23L 110
A23L 132
US Classification:
426662
Abstract:
Enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs) and a process for making such enteral compositions are described. More particularly, the invention relates to enteral compositions which provide long chain PUFAs arachidonic acid (AA) and docosahexaenoic acid (DHA) essentially free of cholesterol and may be derived from egg yolk lipids, and thus are predominantly in a phospholipid form. The process of making such a composition provides improved organoleptic and stability properties. Enteral compositions according to this invention may be used to feed infants, particularly pre-term infants, to promote neural development and development of visual acuity, and to reduce the incidence of necrotizing enterocolitis.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.